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Abstract
The association between regional fat mass distribution and cardiometabolic risk factors has been
inconsistent in the literature, and data for ethnic minority groups, such as non-Hispanic blacks and
Hispanics, are lacking. We aimed to examine this association among 8802 US residents who
participated in the 1999-2004 US National Health and Nutrition Examination Survey (NHANES).
Body composition was measured using dual-energy X-ray absorptiometry (DXA). Leg fat indices
included leg fat mass (FM), leg fat mass percent (FM%), leg to whole body FM ratio (leg/whole)
and leg to trunk FM ratio (leg/trunk). We evaluated the correlation between leg fat indices and
adiposity-related risk factors, as well as the association of these indices with metabolic syndrome
(MetS). After adjusting for covariates including age, gender, and trunk FM or trunk FM%, higher
leg FM and leg FM% were, in general, correlated favorably with adiposity-related risk factors and
associated with lower odds of MetS in all ethnicities, including non-Hispanic whites and blacks
and Hispanic groups. In addition, in all multivariate-adjusted models, leg/whole and leg/trunk
ratios were strongly associated with lower levels of most risk factors and decreased odds of MetS
in these ethnicities (all odds ratios comparing extreme quintiles < 0.1). Our results show that leg
fat accumulation is inversely associated with adiposity-related biological factors and risk of MetS
in both whites and ethnic groups, suggesting that regional fat distribution plays an important role
in the etiology of adiposity-related diseases in these populations.
INTRODUCTION
Over the past three decades, the prevalence of overweight and obesity has tripled in the
United States, resulting in a serious public health problem, which has placed a substantial
burden on the healthcare system (1). Obesity is an important risk factor for the morbidity
and mortality of many chronic diseases. Numerous studies have consistently shown that total
body fat, particularly abdominal fat accumulation, has been strongly associated with
elevated levels of several cardiometabolic risk factors (1) and increased risk of metabolic
syndrome (MetS) (2), type 2 diabetes (3) and cardiovascular disease (CVD) (4). On the
other hand, rich data also suggest that fat accumulation in leg or other peripheral regions
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tmay possess potentially beneficial effects on cardiometabolic health,(5-18) although these
studies were conducted primarily among whites or Asians. It is largely unknown whether leg
fat distribution is associated with cardiometabolic outcomes among other ethnicities with
different body fat distribution and metabolic risk, such as non-Hispanic blacks or Hispanics.
(1, 19)
Recently, we found significant correlations between whole body and trunk fat mass (FM) or
fat mass percent (FM%) as directly measured using dual-energy X-ray absorptiometry
(DXA) with obesity-related biological factors among more than 8000 adults in the National
Health and Nutrition Examination Surveys (NHANES) (20). In the current investigation, we
utilized the same data to comprehensively examine various leg fat indices in relation to
adiposity-related factors and risk of MetS by ethnicity in this large nationally representative
sample of US adults.
METHODS AND PROCEDURES
Study population
This study was conducted using data from 3 representative cross-sectional NHANES
surveys (1999-2004) that included 31 126 individuals randomly selected from the total
civilian, noninstitutionalized US population. African Americans, Mexican Americans, and
elderly residents were oversampled to provide more accurate estimates of their
characteristics, and each respondent was assigned a weight based on geographic and
demographic characteristics to allow for the calculation of population-based estimates. The
NHANES sample design and data collection methods have been described in detail
elsewhere (21). All procedures were approved by the National Center for Health Statistics
Institutional Review Board, and all subjects provided written informed consent.
The present analysis was restricted within NHANES adult participants ≥20 years who were
eligible to DXA assessments (n = 14 213). Of these participants, we excluded participants
with missing DXA measurements (n = 1122) and participants who took medications for
hypertension, high cholesterol or diabetes as these medications can obscure the correlations
of interest (n = 4020). We further excluded a small proportion of participants (n = 269) who
were not non-Hispanic whites or blacks or Hispanic groups based on the considerations that
this group was heterogeneous with respect to ethnicity and the sample size was small to
derive stable statistical estimates. After these exclusions, 8802 participants remained in the
analysis, and, of them, 1734 of these participants had one or more missing DXA
measurements imputed.
Anthropometry and DXA measurements
Body weight, standing height, and waist circumference were assessed by direct
measurement following a standard protocol (21). Body mass index (BMI) was calculated as
weight divided by height squared (kg/m2). Whole-body DXA scans were performed using a
Hologic QDR 4500A fan beam densitometer (Hologic Inc., Bedford, MA). Original DXA
scan results were analyzed using Hologic Discovery software, version 12.1 (Hologic Inc.,
Bedford, MA). Missing DXA data were imputed using sequential regression multivariate
imputation. In the current analysis, we evaluated leg FM (kg), leg FM% calculated as leg
FM divided by total leg mass (kg), leg to whole-body FM (leg/whole) ratio calculated as leg
FM divided by whole body FM, and leg to trunk FM (leg/trunk) ratio calculated as leg FM
divided by trunk FM.
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tAssessment of cardiometabolic risk factors
Systolic blood pressure (SBP), diastolic blood pressure (DBP), serum total cholesterol (TC),
low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C),
and triacylglycerol (TG), fasting blood glucose (FBG), fasting serum insulin (FSI), and
serum C-reactive protein (CRP) were the cardiometabolic risk factors evaluated in the
present analysis (20). Because the amount of missing data varied for these biological factors,
to preserve statistical power as much as possible, we used all available data for each of these
factors (20). Thus the sample size differed for each factor: n = 8420 for SBP; 8383 for DBP;
8297 for TC and HDL-C; 3782 for LDL-C; 4056 for TG; 4104 for FBG; 4046 for FSI; and
8340 for CRP.
Definition of MetS
We used the modified National Cholesterol Education Program's Adult Treatment Panel III
criteria such that participants who had 3 or more of the following conditions were
considered to have MetS: waist circumference ≥102 cm in men or ≥88 cm in women; TG
level ≥150 mg/dL; HDL-C level <40 mg/dL in men or <50mg/dL in women; SBP ≥130
mmHg or DBP ≥85 mmHg; and FBG ≥100 mg/dL.
Covariates
Demographic characteristics such as age, gender, ethnicity, smoking status, alcohol
consumption, and physical activity were ascertained by using questionnaire. Ethnicity was
categorized into non-Hispanic white, non-Hispanic black, and Hispanic groups (including
Mexican Americans and other Hispanics); education was categorized as high school or
below, any college, and college graduate or beyond; smoking status was categorized as
nonsmoker, past smoker, or current smoker; alcohol consumption was divided into
nondrinker, 1-3 drinks/day, or ≥ 4 drinks/day; and regular moderate-to-vigorous physical
activity, self-reported CVD, and family history of diabetes and CVD were categorized as yes
or no.
Statistical analysis
We examined all continuous variables for outliers and log-transformed these variables to
improve normality. Sampled-weighted partial Pearson correlation coefficients were
computed to examine the associations among DXA indices and between leg fat indices and
the cardiometabolic risk factors. Multivariate models were adjusted for the above-mentioned
covariates, as well as trunk DXA indices. Multivariate logistic regression models were used
to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for MetS according to
quintiles of leg FM, leg FM%, and leg/whole and leg/trunk ratios adjusted for the same set
of covariates. In logistic regression analyses, we took sample weights and NHANES survey
design into consideration by using Stata SVY LOGIT command.
All analyses were conducted in quintuplicate by using 5 imputation datasets and the mean of
5 estimates was calculated to derive a single combined statistical summary. This approach
was used to calculate point estimates for correlation coefficients and beta coefficients in
logistic regression models. To derive the variance of these point estimates, we applied the
following statistical approaches. Within-imputation variance (W) was calculated as the
average of 5 individual variance estimates (the variance estimator for Fisher's z transformed
Pearson correlation coefficients (22) or the variance estimator for beta coefficients in
logistic regression), and the between-imputation (B) variance was calculated as the sample
variance of the 5 individual estimates, that is,  , in which Qi was the
individual estimate and Q̄ was the mean of the five individual estimates. The total variance
(T) combined the within- and between-imputation variances as follows:  . The
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tdegrees of freedom were determined using the method of Barnard and Rubin (23). We used
47 (number of primary sampling units minus the number of sampling strata) as the degrees
of freedom for complete data (21).
Data were analyzed using SAS, version 9.3 (SAS Institute, Inc., Cary, North Carolina) and
STATA, version 11.0 (Stata Corporation, College Station, Texas). To take into account
multiple comparisons, we used a Bonferroni-corrected P value less than 0.05 (equivalent to
P < 0.00028, corresponding to 0.05 divided by 178 comparisons) as the significant level.
RESULTS
Characteristics of study population
The baseline characteristics for the study participants by ethnicity are presented in Table 1.
Of the 8802 participants, 50.8% (unweighted percentage; n = 4472) of them were non-
Hispanic whites, 30.1% (n = 1683) had Hispanics ethnicity, and the rest 19.1% (n = 2647)
were non-Hispanic blacks. These three ethnic groups had various distributions of age,
education levels, smoking status, physical activity levels, as well as the cardiometabolic risk
markers. In terms of anthropometric measurements, in comparison to non-Hispanic whites,
non-Hispanic blacks had higher BMI and lower fat mass percent in whole body, trunk, and
leg. Although Hispanics and non-Hispanic whites had similar BMI and whole body fat mass
percent, the former ethnic group had higher trunk fat mass percent and lower leg fat mass
percent than the latter group.
Correlation among DXA indices
The Pearson correlation coefficients among DXA indices are presented in Supplementary
Table 1. These DXA indices were highly correlated with each other: correlation coefficients
between the individual DXA indices were in the range of 0.65-0.97 for non-Hispanic whites,
0.73-0.98 for non-Hispanic blacks, and 0.64-0.97 for Hispanic groups. In all three ethnic
groups, we found modest correlation coefficients among leg fat indices and trunk fat indices.
In addition, we found that leg FM was consistently more strongly correlated with trunk FM
than with trunk FM%, and, similarly, leg FM% was more strongly correlated with trunk FM
% than trunk FM.
Leg fat and obesity-related risk factors
Supplementary Table 2 shows the correlations between leg fat indices and adiposity-related
risk factors by ethnicity after adjusting for age, gender, education, and lifestyle factors. In
this analysis, in general, leg FM and leg FM% tended to correlate unfavorably with the
majority of the risk factors in all three ethnic groups, although the strength of correlations
varied across the three groups. In addition, the correlations of leg FM or leg FM% with
HDL-C, fasting insulin and CRP levels were particularly strong.
Trunk fat may confound the correlation between leg fat and the biological factors because
trunk fat was strongly correlated with both leg fat and the factors. Therefore, we further
adjusted for trunk indices (adjusted for trunk FM in analyses for leg FM, and adjusted for
trunk FM% in analyses for leg FM% based on the findings in Supplementary Table 1) to
examine the independent correlations between leg fat indices and the biological factors, and
results are shown in Table 2. After such an adjustment, the direction of the correlations of
leg FM and leg FM% was reversed for most of these risk factors, although the majority of
these correlations did not achieve statistical significance, except that in non-Hispanic whites
and Hispanic groups leg FM and FM% were significantly correlated with HDL-C and/or TG
levels. In contrast, leg/whole and leg/trunk ratios were correlated favorably with the risk
factors (Table 2), and most of these correlations achieved statistical significance with a few
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texceptions: in non-Hispanic blacks the ratios were non-significantly correlated with LDL-C
levels, and in Hispanic groups leg/whole ratio was non-significantly correlated with LDL-C
levels.
Leg fat and metabolic syndrome
Similar to the pattern of association as observed in Supplementary Table 2, leg FM and FM
% were associated with increased odds of MetS when trunk fat indices were not controlled
for (Supplementary Table 3). After further adjustment for trunk FM or trunk FM%,
associations of the opposite direction were observed between leg fat indices and MetS risk
(Table 3). Significant linear trends were observed between higher leg FM% and increased
odds of MetS among all three ethnic groups, although leg FM was non-significantly
associated lower odds of MetS in these groups. Moreover, in all multivariate-adjusted
models, odds of MetS was consistently lower across higher quintiles of the leg/whole and
leg/trunk ratios. Regardless of ethnicity, participants in the highest quintile of leg/whole and
leg/trunk ratios had dramatically lower odds of MetS (all ORs < 0.1 with significant
Bonferroni-corrected P values for trend).
DISCUSSION
In this large nation-representative U.S. population we found that, regardless of ethnicity, leg
fat indices tended to correlate with favorable profiles of adiposity-related risk factors after
controlling for trunk fat. In addition, leg/whole and leg/trunk ratios were strongly associated
with favorable profiles of these factors and lower odds of metabolic syndrome. These results
suggest that, for a given magnitude of central or whole body adiposity, a larger proportion of
leg fat may have a protective effect on cardiometabolic health.
These results are consistent with the majority of previous studies using DXA or other
imaging techniques to assess the contributions of leg fat on cardiometabolic risk factors and
MetS. Williams et al. (5) firstly reported that the amount of leg fat was inversely correlated
with blood pressure and serum lipid levels in 224 white women aged 17 to 77 years after
adjusting for age, menopause status, and other fat-distribution variables. Subsequent studies
conducted among white populations (8, 9, 11, 12, 14) or participants with unidentified
ethnicity (6, 7, 10, 15-17) corroborated the favorable associations of leg fat or peripheral fat
to central fat ratio with cardiometabolic risk factors, although most of these studies had
small sample sizes that may explain null findings for some of the associations. Data for
other ethnicities are rare. In two investigations conducted among Asian populations, a
similar favorable association was observed between leg fat mass and a wide array of
cardiometabolic risk factors (13, 18). Consistently, in a small sample of Japanese women
Okura et al found that loss of leg fat was associated with adverse change of cardiometabolic
risk factors (24). To our knowledge, the current study provided the first evidence in this
regard for non-Hispanic blacks and Hispanics. These ethnic groups have different body fat
distribution(19) and metabolic risk profiles(1) from non-Hispanic whites. For example, non-
Hispanic blacks tend to have lower body fatness that non-Hispanic whites (25), and
Hispanic males and females generally have higher body fatness than non-Hispanic whites
and blacks (26, 27). With respect to metabolic risk, non-Hispanic blacks and Hispanics have
higher prevalence of metabolic syndrome and its components than non-Hispanic whites (1).
In the current investigation, although the strength and significance of associations may vary
among non-Hispanic whites and blacks and Hispanics probably because of various sample
sizes, we found consistent patterns of favorable associations between leg fat accumulation
and cardiometabolic risk factors or metabolic syndrome in all three ethnic groups. In
addition, the current study supports the notion that fat distribution as measured by leg to
trunk fat and leg to whole-body fat ratios may provide substantially additional information
in reflecting the severity of obesity beyond that of absolute amount of fat accumulation
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twithin specific regions of the body. Overall, all existing evidence consistently suggests that,
in various ethnicities, increased peripheral fat mass accumulation, as well as peripheral to
central fat mass ratio, may add to the prediction of insulin sensitivity over visceral adipose
tissue and central fat mass alone.
The biological mechanisms for the potentially beneficial effects of leg fat accumulation on
adiposity-related risk factors and risk of MetS are not entirely clear. Goodpaster et al (28)
found that the vast majority of leg fat is located in subcutaneous adipose tissues, which may
serve as a metabolic sink where free fatty acid (FFA) and glycerol are stored as triglycerides
to buffer an energy surplus (29, 30). For given levels of trunk or whole body fat, a relatively
larger amount of leg fat would lead to decreased accumulation of ectopic fat at undesirable
sites (31). In addition, evidence shows that adipocytes in the gluteal or femoral region are
less sensitive to factors stimulating lipolysis and have lower rate of lipolysis than in
abdominal regions (32, 33). Moreover, basal FFA turnover rate is lower in peripheral-obese
women than in central-obese women (34), and a greater uptake of circulating FFA was
observed in femoral fat than in abdominal fat (35). As a result, compared to abdominal fat,
high leg fat accumulation may lead to lower FFA concentrations in the portal vein,
decreased triglyceride synthesis, and increased hepatic insulin clearance. Besides FFA, in
comparison to visceral adipose tissue, peripheral adipose tissue also secrets lower levels of
other detrimental adipokines, including tumor necrosis factor alpha (TNF-α) and
plasminogen activator inhibitor-1(PAI-1), but higher levels of adiponectin (36-39). Gene
expression of metabolic enzymes and related signaling proteins were also documented to be
regionally different (40). These mechanisms collectively may underlie the protective effects
of leg fat.
The primary limitation of our study is the use of cross-sectional study design, which
prohibits us from inferring causality in the associations between leg fat and the
cardiometabolic risk factors or MetS. Also, DXA is unable to distinguish between
subcutaneous and intramuscular fat in the legs or between visceral and subcutaneous fat in
the trunk. Therefore, we were unable to ascertain whether the favorable effects of leg fat on
cardiometabolic risk factors and MetS were due to subcutaneous or intramuscular fat, and
we could not additionally adjust for abdominal visceral or subcutaneous fat. It is possible
that the effects of leg fat on risk factors or MetS vary by anatomic site. These results warrant
further confirmation using more sophisticated imaging methods in large prospective studies.
Lastly, we did not examine the associations of interest among other ethnic groups, such as
Native Americans and Asian Americans because of small sample size for these ethnic
minorities. Nevertheless, the strengths of our study include the use of data from NHANES
1999-2004 surveys, which were based on very large nationally representative samples with
standardized data collection methods. Therefore, our results are more generalizable than
those from previous studies. In addition, we carefully adjusted for potential confounders and
excluded participants who took medications that lower the levels of cardiometabolic risk
factors to minimize the strong confounding by existing chronic diseases.
In conclusion, in this large, nationally representative population, we demonstrate favorable
associations of leg fat with a number of adiposity-related risk factors and risk of MetS after
controlling for trunk fat in non-Hispanic blacks and Hispanics, as well as in non-Hispanic
whites. Moreover, regardless of ethnicity, fat distribution as reflected by leg/whole and leg/
trunk fat ratios may be more biologically meaningful in evaluating the adverse effects of
obesity than absolute fat depot in certain regions. Our findings may thus provide new insight
into the role of adiposity in cardiometabolic risk.
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Table 1
Characteristics of study participants by ethnicity
a, NHANES, 1999-2004
Characteristicsb Non-Hispanic white (n =
4472c)
Non-Hispanic black (n =
1683c)
Hispanic groups (n =
2647c)
Weighted percentage (%) 74.3 10.7 15.0
Unweighted percentage (%) 50.8 19.1 30.1
Age (yr) 43.2 (0.3) 38.4 (0.2) 37.4 (0.6)
Male (%) 2267 (49.3) 878 (48.7) 1378 (52.0)
BMI (kg/m2) 27.0 (0.1) 28.7 (0.2) 27.8 (0.2)
Waist circumference (cm) 94.0 (0.3) 94.1 (0.5) 93.4 (0.5)
Whole body FM (kg) 26.8 (0.2) 28.0 (0.3) 25.8 (0.3)
Whole body FM% 33.1 (0.2) 32.2 (0.2) 33.5 (0.2)
Trunk FM (kg) 13.0 (0.1) 12.8 (0.2) 12.9 (0.2)
Trunk FM% 32.3 (0.2) 31.4 (0.2) 33.7 (0.3)
Leg FM (kg) 9.5 (0.1) 10.7 (0.1) 8.7 (0.1)
Leg FM% 35.3 (0.2) 34.5 (0.3) 34.6 (0.2)
Education (%)
    High school and below 1885 (39.2) 960 (55.5) 1981 (66.2)
    College 1339 (31.3) 491 (30.4) 477 (23.3)
    College graduate and above 1248 (29.5) 232 (14.1) 189 (10.5)
Smoking status (%)
    Never smoked 2249 (51.8) 1036 (63.7) 1687 (65.1)
    Past smoker 1180 (23.8) 219 (11.1) 579 (18.7)
    Current smoker 1043 (24.4) 428 (25.2) 381 (16.2)
Alcohol use (%)
    Non-drinkers 1361 (27.8) 685 (40.2) 956 (32.6)
    1-3 drinks/day 2427 (55.3) 773 (46.5) 1026 (39.8)
    4+ drinks/day 684 (16.9) 225 (13.3) 665 (27.6)
Moderate to vigorous physical activity (%)d 2989 (70.5) 889 (54.6) 1238 (53.6)
Cardiometabolic risk factorse
    SBP (mmHg) 120.0 (0.4) 122.6 (0.5) 118.1 (0.7)
    DBP (mmHg) 72.3 (0.3) 73.6 (0.4) 70.6 (0.4)
    TC (mg/dL) 203.3 (0.9) 191.2 (1.2) 197.6 (1.4)
    LDL-C (mg/dL) 123.6 (0.9) 115.0 (1.4) 118.9 (1.5)
    HDL-C (mg/dL) 52.7 (0.5) 54.7 (0.6) 48.9 (0.5)
    TG (mg/dL) 142.5 (4.3) 101.5 (2.4) 148.3 (6.1)
    CRP (mg/dL) 0.34 (0.01) 0.48 (0.03) 0.41 (0.03)
    FBG (mg/dL) 96.4 (0.6) 94.7 (0.9) 98.1 (0.9)
    FSI (μU/mL) 10.2 (0.3) 12.4 (0.4) 13.0 (0.5)
Abbreviations: BMI, body mass index; FM, fat mass; FM%, fat mass percent; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC,
total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triacylglycerol; CRP, C-reactive
protein; FBG, fasting blood glucose; FSI, fasting serum insulin.
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a
Hispanic groups include American Mexican and other Hispanic groups in the NHANES surveys.
b
Values are mean (SE) for continuous variables and numbers (weighted percentage) for categorical variables.
c
Unweighted number of participants.
d
Based on non-missing data only.
e
n = 8420 for SBP; 8383 for DBP; 8297 for TC and HDL-C; 3782 for LDL-C; 4056 for TG; 4104 for FBG; 4046 for FSI; and 8340 for CRP.
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